Advanced Solid Tumor
Showing NaN - NaN of 63
Advanced Solid Tumor Trial in China (IO-108, IO-108 + pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
- IO-108
- IO-108 + pembrolizumab
-
Changsha, Hunan, China
- +3 more
Aug 18, 2022
Advanced Solid Tumor, BRAF V600 Mutation Trial in Nanchang, Jinan, Shanghai (ABM-1310)
Not yet recruiting
- Advanced Solid Tumor
- BRAF V600 Mutation
-
Nanchang, Jiangxi, China
- +2 more
Aug 12, 2022
Advanced Solid Tumor Trial in China (PD-1 mAb injection, TJ004309 Injection)
Recruiting
- Advanced Solid Tumor
- PD-1 monoclonal antibody injection
- TJ004309 Injection
-
Hefei, Anhui, China
- +25 more
Aug 2, 2022
Advanced Solid Tumor Trial in China (TJ1133 Injection)
Recruiting
- Advanced Solid Tumor
- TJ1133 Injection
-
Bengbu, Anhui, China
- +23 more
Jul 17, 2022
Advanced Solid Tumor Trial in Shanghai (TJ210001 Injection)
Recruiting
- Advanced Solid Tumor
- TJ210001 Injection
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Jun 24, 2022
Advanced Solid Tumor Trial in Shanghai (SY-4835)
Recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiaotong University School
Mar 11, 2022
Advanced Solid Tumor Trial in Shanghai (RC118-ADC)
Recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Mar 21, 2022
Advanced Solid Tumor Trial in Shanghai (HS-20089 (Phase Ia:Dose escalation ), HS-20089 (Phase Ib: Dose expansion))
Recruiting
- Advanced Solid Tumor
- HS-20089 (Phase Ia:Dose escalation )
- HS-20089 (Phase Ib: Dose expansion)
-
Shanghai, Shanghai, ChinaFudan University Cancer Hospital
Feb 21, 2022
Advanced Solid Tumor, Cholangiocarcinoma, Biliary Tract Cancer Trial in Beijing, Jinan, Shanghai (TT-00420, Combination Product:
Not yet recruiting
- Advanced Solid Tumor
- +10 more
- TT-00420
- +2 more
-
Beijing, China
- +3 more
Feb 14, 2022
Advanced Solid Tumor Trial in New York, Beijing, Shanghai (NB003 tablets)
Recruiting
- Advanced Solid Tumor
- NB003 tablets
-
New York, New York
- +2 more
Jan 29, 2022
Advanced Solid Tumor Trial in Shanghai (SHR6390?Omeprazole)
Active, not recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Jan 11, 2022
Advanced Solid Tumor Trial in Shanghai (LM-302 Injection)
Recruiting
- Advanced Solid Tumor
- LM-302 Injection
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Dec 29, 2021
Advanced Solid Tumor Trial in Shanghai (MRG002)
Recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaShanghai Oriental Hospital
Dec 2, 2021
Advanced Solid Tumor Trial in Shanghai (LM-102 Injection, LM-102 Injection combined with SOC)
Recruiting
- Advanced Solid Tumor
- LM-102 Injection
- LM-102 Injection combined with SOC
-
Shanghai, Shanghai, ChinaFudan Zhongshan Hospital
Nov 5, 2021
Advanced Solid Tumor Trial in China (Mitoxantrone Hydrochloride Liposome, intravenous injection (IV))
Active, not recruiting
- Advanced Solid Tumor
- Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
-
Bengbu, Anhui, China
- +7 more
Oct 28, 2021
Advanced Solid Tumor Trial in Hangzhou, Shanghai (MSB0254 Injection)
Recruiting
- Advanced Solid Tumor
- MSB0254 Injection
-
Hangzhou, Zhejiang, China
- +1 more
Oct 7, 2021
Advanced Solid Tumor Trial in Shanghai (HS269)
Not yet recruiting
- Advanced Solid Tumor
-
Shanghai, ChinaShanghai Pulmonary Hospital
Sep 24, 2021
Liposarcoma, Advanced Solid Tumor Trial in Guangzhou, Shanghai (APG-115, Toripalimab)
Recruiting
- Liposarcoma
- Advanced Solid Tumor
-
Guangzhou, Guangdong, China
- +1 more
Sep 22, 2021
Advanced Solid Tumor Trial in Shanghai (FCN-011)
Recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 16, 2021
Advanced Solid Tumor, Breast Tumors Trial in Shanghai (BPI-1178, Fulvestrant, Letrozole)
Recruiting
- Advanced Solid Tumor
- Breast Neoplasms
- BPI-1178
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 28, 2021